Global Human DNA Vaccines Market Growth (Status and Outlook) 2025-2031

September 2025 | 81 pages | ID: G82C80FCB98EN
LP Information

Abstracts

According to this study, the global Human DNA Vaccines market size will reach US$ 5357 million by 2031.

DNA vaccines have evolved greatly over the last 20 years since their invention, but have yet to become a competitive alternative to conventional protein or carbohydrate based human vaccines. Whilst safety concerns were an initial barrier, the Achilles heel of DNA vaccines remains their poor immunogenicity when compared to protein vaccines. A wide variety of strategies have been developed to optimize DNA vaccine immunogenicity, including codon optimization, genetic adjuvants, electroporation and sophisticated prime-boost regimens, with each of these methods having its advantages and limitations. Whilst each of these methods has contributed to incremental improvements in DNA vaccine efficacy, more is still needed if human DNA vaccines are to succeed commercially.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Human DNA Vaccines Industry Forecast” looks at past sales and reviews total world Human DNA Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Human DNA Vaccines sales for 2025 through 2031. With Human DNA Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human DNA Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Human DNA Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human DNA Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human DNA Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human DNA Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human DNA Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Human DNA Vaccines market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Recombinant Protein Vaccine
• Gene-Based Vaccine

Segmentation by Application:

• Influenza
• Human Papillomavirus
• HIV

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Merck
• GSK
• Sanofi
• Zoties
• Elanco
• Boehringer-Ingelheim
• Indian Immunologicals
• Plumbline Life Sciences

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Human DNA Vaccines Market Size (2020-2031)
  2.1.2 Human DNA Vaccines Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Human DNA Vaccines by Country/Region (2020, 2024 & 2031)
2.2 Human DNA Vaccines Segment by Type
  2.2.1 Recombinant Protein Vaccine
  2.2.2 Gene-Based Vaccine
2.3 Human DNA Vaccines Market Size by Type
  2.3.1 Human DNA Vaccines Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Human DNA Vaccines Market Size Market Share by Type (2020-2025)
2.4 Human DNA Vaccines Segment by Application
  2.4.1 Influenza
  2.4.2 Human Papillomavirus
  2.4.3 HIV
2.5 Human DNA Vaccines Market Size by Application
  2.5.1 Human DNA Vaccines Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Human DNA Vaccines Market Size Market Share by Application (2020-2025)

3 HUMAN DNA VACCINES MARKET SIZE BY PLAYER

3.1 Human DNA Vaccines Market Size Market Share by Player
  3.1.1 Global Human DNA Vaccines Revenue by Player (2020-2025)
  3.1.2 Global Human DNA Vaccines Revenue Market Share by Player (2020-2025)
3.2 Global Human DNA Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HUMAN DNA VACCINES BY REGION

4.1 Human DNA Vaccines Market Size by Region (2020-2025)
4.2 Global Human DNA Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human DNA Vaccines Market Size Growth (2020-2025)
4.4 APAC Human DNA Vaccines Market Size Growth (2020-2025)
4.5 Europe Human DNA Vaccines Market Size Growth (2020-2025)
4.6 Middle East & Africa Human DNA Vaccines Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Human DNA Vaccines Market Size by Country (2020-2025)
5.2 Americas Human DNA Vaccines Market Size by Type (2020-2025)
5.3 Americas Human DNA Vaccines Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Human DNA Vaccines Market Size by Region (2020-2025)
6.2 APAC Human DNA Vaccines Market Size by Type (2020-2025)
6.3 APAC Human DNA Vaccines Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Human DNA Vaccines Market Size by Country (2020-2025)
7.2 Europe Human DNA Vaccines Market Size by Type (2020-2025)
7.3 Europe Human DNA Vaccines Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Human DNA Vaccines by Region (2020-2025)
8.2 Middle East & Africa Human DNA Vaccines Market Size by Type (2020-2025)
8.3 Middle East & Africa Human DNA Vaccines Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HUMAN DNA VACCINES MARKET FORECAST

10.1 Global Human DNA Vaccines Forecast by Region (2026-2031)
  10.1.1 Global Human DNA Vaccines Forecast by Region (2026-2031)
  10.1.2 Americas Human DNA Vaccines Forecast
  10.1.3 APAC Human DNA Vaccines Forecast
  10.1.4 Europe Human DNA Vaccines Forecast
  10.1.5 Middle East & Africa Human DNA Vaccines Forecast
10.2 Americas Human DNA Vaccines Forecast by Country (2026-2031)
  10.2.1 United States Market Human DNA Vaccines Forecast
  10.2.2 Canada Market Human DNA Vaccines Forecast
  10.2.3 Mexico Market Human DNA Vaccines Forecast
  10.2.4 Brazil Market Human DNA Vaccines Forecast
10.3 APAC Human DNA Vaccines Forecast by Region (2026-2031)
  10.3.1 China Human DNA Vaccines Market Forecast
  10.3.2 Japan Market Human DNA Vaccines Forecast
  10.3.3 Korea Market Human DNA Vaccines Forecast
  10.3.4 Southeast Asia Market Human DNA Vaccines Forecast
  10.3.5 India Market Human DNA Vaccines Forecast
  10.3.6 Australia Market Human DNA Vaccines Forecast
10.4 Europe Human DNA Vaccines Forecast by Country (2026-2031)
  10.4.1 Germany Market Human DNA Vaccines Forecast
  10.4.2 France Market Human DNA Vaccines Forecast
  10.4.3 UK Market Human DNA Vaccines Forecast
  10.4.4 Italy Market Human DNA Vaccines Forecast
  10.4.5 Russia Market Human DNA Vaccines Forecast
10.5 Middle East & Africa Human DNA Vaccines Forecast by Region (2026-2031)
  10.5.1 Egypt Market Human DNA Vaccines Forecast
  10.5.2 South Africa Market Human DNA Vaccines Forecast
  10.5.3 Israel Market Human DNA Vaccines Forecast
  10.5.4 Turkey Market Human DNA Vaccines Forecast
10.6 Global Human DNA Vaccines Forecast by Type (2026-2031)
10.7 Global Human DNA Vaccines Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Human DNA Vaccines Forecast

11 KEY PLAYERS ANALYSIS

11.1 Merck
  11.1.1 Merck Company Information
  11.1.2 Merck Human DNA Vaccines Product Offered
  11.1.3 Merck Human DNA Vaccines Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Merck Main Business Overview
  11.1.5 Merck Latest Developments
11.2 GSK
  11.2.1 GSK Company Information
  11.2.2 GSK Human DNA Vaccines Product Offered
  11.2.3 GSK Human DNA Vaccines Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 GSK Main Business Overview
  11.2.5 GSK Latest Developments
11.3 Sanofi
  11.3.1 Sanofi Company Information
  11.3.2 Sanofi Human DNA Vaccines Product Offered
  11.3.3 Sanofi Human DNA Vaccines Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Sanofi Main Business Overview
  11.3.5 Sanofi Latest Developments
11.4 Zoties
  11.4.1 Zoties Company Information
  11.4.2 Zoties Human DNA Vaccines Product Offered
  11.4.3 Zoties Human DNA Vaccines Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Zoties Main Business Overview
  11.4.5 Zoties Latest Developments
11.5 Elanco
  11.5.1 Elanco Company Information
  11.5.2 Elanco Human DNA Vaccines Product Offered
  11.5.3 Elanco Human DNA Vaccines Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Elanco Main Business Overview
  11.5.5 Elanco Latest Developments
11.6 Boehringer-Ingelheim
  11.6.1 Boehringer-Ingelheim Company Information
  11.6.2 Boehringer-Ingelheim Human DNA Vaccines Product Offered
  11.6.3 Boehringer-Ingelheim Human DNA Vaccines Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Boehringer-Ingelheim Main Business Overview
  11.6.5 Boehringer-Ingelheim Latest Developments
11.7 Indian Immunologicals
  11.7.1 Indian Immunologicals Company Information
  11.7.2 Indian Immunologicals Human DNA Vaccines Product Offered
  11.7.3 Indian Immunologicals Human DNA Vaccines Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Indian Immunologicals Main Business Overview
  11.7.5 Indian Immunologicals Latest Developments
11.8 Plumbline Life Sciences
  11.8.1 Plumbline Life Sciences Company Information
  11.8.2 Plumbline Life Sciences Human DNA Vaccines Product Offered
  11.8.3 Plumbline Life Sciences Human DNA Vaccines Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Plumbline Life Sciences Main Business Overview
  11.8.5 Plumbline Life Sciences Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Human DNA Vaccines Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Human DNA Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Recombinant Protein Vaccine
Table 4. Major Players of Gene-Based Vaccine
Table 5. Human DNA Vaccines Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Human DNA Vaccines Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Human DNA Vaccines Market Size Market Share by Type (2020-2025)
Table 8. Human DNA Vaccines Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Human DNA Vaccines Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Human DNA Vaccines Market Size Market Share by Application (2020-2025)
Table 11. Global Human DNA Vaccines Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Human DNA Vaccines Revenue Market Share by Player (2020-2025)
Table 13. Human DNA Vaccines Key Players Head office and Products Offered
Table 14. Human DNA Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Human DNA Vaccines Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Human DNA Vaccines Market Size Market Share by Region (2020-2025)
Table 19. Global Human DNA Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Human DNA Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Human DNA Vaccines Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Human DNA Vaccines Market Size Market Share by Country (2020-2025)
Table 23. Americas Human DNA Vaccines Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Human DNA Vaccines Market Size Market Share by Type (2020-2025)
Table 25. Americas Human DNA Vaccines Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Human DNA Vaccines Market Size Market Share by Application (2020-2025)
Table 27. APAC Human DNA Vaccines Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Human DNA Vaccines Market Size Market Share by Region (2020-2025)
Table 29. APAC Human DNA Vaccines Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Human DNA Vaccines Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Human DNA Vaccines Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Human DNA Vaccines Market Size Market Share by Country (2020-2025)
Table 33. Europe Human DNA Vaccines Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Human DNA Vaccines Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Human DNA Vaccines Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Human DNA Vaccines Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Human DNA Vaccines Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Human DNA Vaccines
Table 39. Key Market Challenges & Risks of Human DNA Vaccines
Table 40. Key Industry Trends of Human DNA Vaccines
Table 41. Global Human DNA Vaccines Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Human DNA Vaccines Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Human DNA Vaccines Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Human DNA Vaccines Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Merck Details, Company Type, Human DNA Vaccines Area Served and Its Competitors
Table 46. Merck Human DNA Vaccines Product Offered
Table 47. Merck Human DNA Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Merck Main Business
Table 49. Merck Latest Developments
Table 50. GSK Details, Company Type, Human DNA Vaccines Area Served and Its Competitors
Table 51. GSK Human DNA Vaccines Product Offered
Table 52. GSK Human DNA Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. GSK Main Business
Table 54. GSK Latest Developments
Table 55. Sanofi Details, Company Type, Human DNA Vaccines Area Served and Its Competitors
Table 56. Sanofi Human DNA Vaccines Product Offered
Table 57. Sanofi Human DNA Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Sanofi Main Business
Table 59. Sanofi Latest Developments
Table 60. Zoties Details, Company Type, Human DNA Vaccines Area Served and Its Competitors
Table 61. Zoties Human DNA Vaccines Product Offered
Table 62. Zoties Human DNA Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Zoties Main Business
Table 64. Zoties Latest Developments
Table 65. Elanco Details, Company Type, Human DNA Vaccines Area Served and Its Competitors
Table 66. Elanco Human DNA Vaccines Product Offered
Table 67. Elanco Human DNA Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Elanco Main Business
Table 69. Elanco Latest Developments
Table 70. Boehringer-Ingelheim Details, Company Type, Human DNA Vaccines Area Served and Its Competitors
Table 71. Boehringer-Ingelheim Human DNA Vaccines Product Offered
Table 72. Boehringer-Ingelheim Human DNA Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Boehringer-Ingelheim Main Business
Table 74. Boehringer-Ingelheim Latest Developments
Table 75. Indian Immunologicals Details, Company Type, Human DNA Vaccines Area Served and Its Competitors
Table 76. Indian Immunologicals Human DNA Vaccines Product Offered
Table 77. Indian Immunologicals Human DNA Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Indian Immunologicals Main Business
Table 79. Indian Immunologicals Latest Developments
Table 80. Plumbline Life Sciences Details, Company Type, Human DNA Vaccines Area Served and Its Competitors
Table 81. Plumbline Life Sciences Human DNA Vaccines Product Offered
Table 82. Plumbline Life Sciences Human DNA Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Plumbline Life Sciences Main Business
Table 84. Plumbline Life Sciences Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Human DNA Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human DNA Vaccines Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Human DNA Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Human DNA Vaccines Sales Market Share by Country/Region (2024)
Figure 8. Human DNA Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Human DNA Vaccines Market Size Market Share by Type in 2024
Figure 10. Human DNA Vaccines in Influenza
Figure 11. Global Human DNA Vaccines Market: Influenza (2020-2025) & ($ millions)
Figure 12. Human DNA Vaccines in Human Papillomavirus
Figure 13. Global Human DNA Vaccines Market: Human Papillomavirus (2020-2025) & ($ millions)
Figure 14. Human DNA Vaccines in HIV
Figure 15. Global Human DNA Vaccines Market: HIV (2020-2025) & ($ millions)
Figure 16. Global Human DNA Vaccines Market Size Market Share by Application in 2024
Figure 17. Global Human DNA Vaccines Revenue Market Share by Player in 2024
Figure 18. Global Human DNA Vaccines Market Size Market Share by Region (2020-2025)
Figure 19. Americas Human DNA Vaccines Market Size 2020-2025 ($ millions)
Figure 20. APAC Human DNA Vaccines Market Size 2020-2025 ($ millions)
Figure 21. Europe Human DNA Vaccines Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Human DNA Vaccines Market Size 2020-2025 ($ millions)
Figure 23. Americas Human DNA Vaccines Value Market Share by Country in 2024
Figure 24. United States Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Human DNA Vaccines Market Size Market Share by Region in 2024
Figure 29. APAC Human DNA Vaccines Market Size Market Share by Type (2020-2025)
Figure 30. APAC Human DNA Vaccines Market Size Market Share by Application (2020-2025)
Figure 31. China Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 35. India Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Human DNA Vaccines Market Size Market Share by Country in 2024
Figure 38. Europe Human DNA Vaccines Market Size Market Share by Type (2020-2025)
Figure 39. Europe Human DNA Vaccines Market Size Market Share by Application (2020-2025)
Figure 40. Germany Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 41. France Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Human DNA Vaccines Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Human DNA Vaccines Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Human DNA Vaccines Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Human DNA Vaccines Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 54. APAC Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 55. Europe Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 57. United States Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 58. Canada Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 59. Mexico Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 60. Brazil Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 61. China Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 62. Japan Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 63. Korea Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 65. India Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 66. Australia Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 67. Germany Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 68. France Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 69. UK Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 70. Italy Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 71. Russia Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 72. Egypt Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 73. South Africa Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 74. Israel Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 75. Turkey Human DNA Vaccines Market Size 2026-2031 ($ millions)
Figure 76. Global Human DNA Vaccines Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Human DNA Vaccines Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Human DNA Vaccines Market Size 2026-2031 ($ millions)